טוען...
Assessing the accuracy of the OMRON HEM‐907XL oscillometric blood pressure measurement device in patients with nondialytic chronic kidney disease
The OMRON HEM−907XL is a commercial oscillometric blood pressure (BP) monitor that was used in the Systolic Blood Pressure Intervention Trial (SPRINT), in which 28% of participants had chronic kidney disease (CKD). This study examined the accuracy of the monitor in nondialytic patients with CKD. Eig...
שמור ב:
| הוצא לאור ב: | J Clin Hypertens (Greenwich) |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley and Sons Inc.
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5340575/ https://ncbi.nlm.nih.gov/pubmed/28079300 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jch.12961 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|